A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The optimal dosage and duration of administration of clot-dissolving medications for the
treatment of patients with mechanical heart valves with clots is not known. We hypothesized
that a large dose of the clot-dissolving medicine given initially (akin to the dose given in
the treatment of heart attacks), might speed up the dissolution of the clot and rapidly
restore the functioning of the mechanical heart valve.
Phase:
Phase 3
Details
Lead Sponsor:
All India Institute of Medical Sciences, New Delhi